Zobrazeno 1 - 10
of 26
pro vyhledávání: '"J. Weber-Arden"'
Autor:
J. B. Kuemmerle-Deschner, J. Henes, B. Kortus-Goetze, T. Kallinich, P. Oommen, J. Rech, T. Krickau, F. Weller-Heinemann, G. Horneff, A. Janda, I. Foeldvari, C. Schuetz, F. Dressler, M. Borte, M. Hufnagel, F. Meier, M. Fiene, J. Weber-Arden, N. Blank
Publikováno v:
Annals of the Rheumatic Diseases. 81:1026-1027
BackgroundAutoinflammatory diseases (AID) are characterized by severe systemic and organ inflammation as well as high burden of disease for patients and their families. Treatment with the monoclonal antibody canakinumab (CAN), an interleukin-1β inhi
Autor:
J. B. Kuemmerle-Deschner, B. Kortus-Goetze, P. Oommen, A. Janda, J. Rech, C. Schuetz, T. Kallinich, F. Weller-Heinemann, G. Horneff, I. Foeldvari, F. Meier, M. Borte, T. Krickau, J. Weber-Arden, N. Blank
Publikováno v:
Annals of the Rheumatic Diseases. 81:346-347
BackgroundThe cryopyrin-associated periodic fever syndromes (CAPS) are hereditary monogenic autoinflammatory diseases with severe systemic and organ inflammation due to increased production of Interleukin-1β (IL-1β). The subcutaneously administered
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
J. Henes, J. B. Kuemmerle-Deschner, T. Krickau, T. Kallinich, F. Dressler, G. Horneff, F. Meier, I. Foeldvari, F. Weller-Heinemann, B. Kortus-Goetze, M. Hufnagel, J. Rech, P. Oommen, J. Weber-Arden, N. Blank
Publikováno v:
Annals of the Rheumatic Diseases. 81:29.1-30
BackgroundFamilial Mediterranean Fever (FMF) is a chronic disease characterized by recurrent attacks of fever as well as serositis and bears the risk of serious complications (e. g. amyloidosis). Treatment of FMF according to EULAR aims to control ac
Publikováno v:
Annals of the Rheumatic Diseases. 81:1027.2-1028
BackgroundHyper-IgD syndrome/mevalonate kinase deficiency (HIDS/MKD) is a rare autoinflammatory condition caused by a defect in the gene coding for mevalonate kinase. This periodic fever syndrome is characterized by severe systemic and organ inflamma
Autor:
N. Blank, C. Schuetz, J. Henes, T. Kallinich, P. Oommen, M. Borte, M. Hufnagel, A. Janda, J. Weber-Arden, J. B. Kuemmerle-Deschner
Publikováno v:
Annals of the Rheumatic Diseases. 81:347.2-347
BackgroundTumor necrosis factor receptor-associated periodic syndrome (TRAPS) is a rare hereditary autoinflammatory disease characterized by periodic fever as well as severe systemic and organ inflammation. Successful treatment was achieved with the
Autor:
Norbert Blank, Prasad T. Oommen, Catharina Schuetz, Tilmann Kallinich, J. B. Kuemmerle-Deschner, Joerg Henes, Michael Borte, J. Weber-Arden
Publikováno v:
Annals of the Rheumatic Diseases. 80:972-973
Background:Tumor necrosis factor receptor-associated periodic syndrome (TRAPS) is a rare autoinflammatory condition characterized by severe systemic and organ inflammation. In a phase 3 pivotal trial (CLUSTER study), TRAPS patients have been successf
Autor:
A. Braner, Catharina Schuetz, I. Foeldvari, Prasad T. Oommen, J. B. Kuemmerle-Deschner, Jürgen Rech, G. Horneff, Tilmann Kallinich, A. Janda, B. Kortus-Goetze, Michael Borte, J. Weber-Arden, Frank Weller-Heinemann, Norbert Blank
Publikováno v:
Annals of the Rheumatic Diseases. 80:50.2-51
Background:In clinical trials as well as in real-life, the IL-1ß inhibitor canakinumab leads to rapid remission of symptoms in the treatment of CAPS, a monogenic autoinflammatory disease with severe systemic and organ inflammation.Objectives:The REL
Autor:
Florian M P Meier, Jörg Henes, Tilmann Kallinich, B. Kortus-Goetze, Norbert Blank, Frank Weller-Heinemann, Markus Hufnagel, Frank Dressler, J. Weber-Arden, G. Horneff, I. Foeldvari, J. B. Kuemmerle-Deschner
Publikováno v:
Annals of the Rheumatic Diseases. 80:971.2-972
Background:Familial Mediterranean Fever (FMF) is characterized by recurrent attacks of fever and serositis as well as elevated inflammatory markers. FMF treatment goals according to EULAR are to control acute attacks and subclinical inflammation and
Autor:
Frank Weller-Heinemann, Norbert Blank, B. Kortus-Goetze, Catharina Schuetz, G. Horneff, I. Foeldvari, Michael Borte, Tilmann Kallinich, Prasad T. Oommen, J. Weber-Arden, J. B. Kuemmerle-Deschner
Publikováno v:
Annals of the Rheumatic Diseases. 79:1211.2-1211
Background:In the treatment of monogenic autoinflammatory diseases (AID), a heterogeneous group of diseases with excessive interleukin (IL)-1β release and severe systemic and organ inflammation, the anti-IL-1 inhibitor canakinumab (CAN) has been ass